Biomarker evaluation of face transplant rejection: Association of donor T cells with target cell injury

Modern Pathology

Volumn 27, Issue 6, 2014, Pages 788-799

  Lian, Christine Guo ^a   Bueno, Ericka M ^a   Granter, Scott R ^a   Laga, Alvaro C ^a   Saavedra, Arturo P ^a   Lin, William M ^a   Susa, Joseph S ^b   Zhan, Qian ^a   Chandraker, Anil K ^a   Tullius, Stefan G ^a   Pomahac, Bohdan ^a   Murphy, George F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

donor T cell; facial transplant; graft versus host disease; skin allograft; T resident memory cells; vascularized composite allotransplantation

Indexed keywords

BIOLOGICAL MARKER;

ADULT; APOPTOSIS; ARTICLE; BIOPSY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DAMAGE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DONOR; FACIAL TRANSPLANTATION; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOPHENOTYPING; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; SKIN ALLOGRAFT; T LYMPHOCYTE; TARGET CELL; ALLOGRAFT; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT VERSUS HOST REACTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MIDDLE AGED;

ADULT; ALLOGRAFTS; BIOLOGICAL MARKERS; FACIAL TRANSPLANTATION; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; GRAFT VS HOST REACTION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; T-LYMPHOCYTES; TISSUE DONORS;

EID: 84901825932     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.249     Document Type: Article

References (46)

1. Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 2013;381:313-319.
2. Bagnasco S, Kraus E, Sis B. Diagnostic criteria for kidney transplant rejection: a call to action. Lancet 2013;381:1458.
3. Gibson T, Medawar PB. The fate of skin homografts in man. J Anat 1943;77:299310 4.
4. Hancock WW, Murphy GF. Skin Grafts and their Rejections in the Pathology of Organ Transplantation. Butterworths: Boston, MA, 1990.
5. Dvorak HF, Mihm MC Jr, Dvorak AM, et al. Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med 1979;150:322-337. (Pubitemid 9220319)
6. Bhan AK, Mihm MC Jr, Dvorak HF. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies. J Immunol 1982;129:1578-1583. (Pubitemid 12031094)
7. Pomahac B, Pribaz J, Eriksson E, et al. Three patients with full facial transplantation. N Engl J Med 2012; 366:715-722.
8. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008;8:1396-1400. (Pubitemid 351989486)
9. Bueno EM, Diaz-Siso JR, Pomahac B. A multidisci-plinary protocol for face transplantation at Brigham and Women's Hospital. J Plast Reconstr Aesthet Surg 2011;64:1572-1579.
10. Hirahara K, Liu L, Clark RA, et al. The majority of human peripheral blood CD4 + CD25highFoxp3 + regulatory T cells bear functional skin-homing receptors. J Immunol 2006;177:4488-4494. (Pubitemid 44469779)
11. Lim HW, Broxmeyer HE, Kim CH. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol 2006;177:840-851. (Pubitemid 44036584)
12. Ariotti S, Beltman JB, Chodaczek G, et al. Tissue-resident memory CD8 + T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc Natl Acad Sci USA 2012;109:19739-19744.
13. Mackay LK, Stock AT, Ma JZ, et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci USA 2012; 109:7037-7042.
14. Mizukawa Y, Yamazaki Y, Teraki Y, et al. Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol 2002;161:1337-1347.
15. Bronstein BR, Murphy GF, Harrist TJ, et al. Location of HLA-A, B, C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study. J Invest Dermatol 1983;80:481-484. (Pubitemid 13062257)
16. Natali PG, Bigotti A, Nicotra MR, et al. Distribution of human Class I (HLA-A, B, C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 1984;44:4679-4687. (Pubitemid 14008799)
17. Caughman SW, Sharrow SO, Shimada S, et al. Ia + murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. Proc Natl Acad Sci USA 1986;83: 7438-7442. (Pubitemid 16000537)
18. Ruckert R, Hofmann U, van der Veen C, et al. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 1998;111:25-30. (Pubitemid 28309204)
19. Wang X, Campoli M, Cho HS, et al. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections. J Immunol Methods 2005;299:139-151. (Pubitemid 40725931)
20. Jiang X, Clark RA, Liu L, et al. Skin infection generates non-migratory memory CD8 + T(RM) cells providing global skin immunity. Nature 2012;483:227-231.
21. Carty MJ, Bueno EM, Lehmann LS, et al. A position paper in support of face transplantation in the blind. Plast Reconstr Surg 2012;130:319-324.
22. Hautz T, Zelger B, Brandacher G, et al. Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts. Transpl Int 2012;25: 56-63.
23. Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation 2012;93: 855-859.
24. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopatho-logic features of graft rejection of the first human hand allograft. Transplantation 2003;76:688-693. (Pubitemid 37072004)
25. Kanitakis J, Badet L, Petruzzo P, et al. Clinicopatholo-gic monitoring of the skin and oral mucosa of the first human face allograft: Report on the first eight months. Transplantation 2006;82:1610-1615. (Pubitemid 46035637)
26. Eljaafari A, Badet L, Kanitakis J, et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation 2006;82:1764-1768. (Pubitemid 46035664)
27. Petruzzo P, Testelin S, Kanitakis J, et al. First human face transplantation: 5 years outcomes. Transplantation 2012;93:236-240.
28. Hautz T, Zelger B, Grahammer J, et al. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant 2010;10:1200-1209.
29. Bergfeld W, Klimczak A, Stratton JS, et al. A 4-year pathology review of the near total face transplant. Am J Transplant 2013;13:2750-2764.
30. Siemionow M, Ozturk C. Face transplantation: outcomes, concerns, controversies, and future directions. J Craniofac Surg 2012;23:254-259.
31. Solez K, Racusen LC. The Banff classification revisited. Kidney Int 2013;83:201-206.
32. Saavedra AP, Bueno EM, Granter SR, et al. Transmission of donor-specific skin condition from donor to recipient of facial allograft. Am J Transplant 2011;11: 1340.
33. Kolgen W, Both H, van Weelden H, et al. Epidermal langerhans cell depletion after artificial ultraviolet B irradiation of human skin in vivo: apoptosis versus migration. J Invest Dermatol 2002;118: 812-817. (Pubitemid 34526543)
34. Gebhardt T, Whitney PG, Zaid A, et al. Different patterns of peripheral migration by memory CD4 and CD8 T cells. Nature 2011;477:216-219.
35. Clark RA, Chong B, Mirchandani N, et al. The vast majority of CLA T cells are resident in normal skin. J Immunol 2006;176:4431-4439. (Pubitemid 44264423)
36. Clark RA, Chong BF, Mirchandani N, et al. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 2006;126:1059-1070.
37. Halprin KM. Epidermal 'turnover time'-a re-examination. Br J Dermatol 1972;86:14-19.
38. Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 1983; 80(Suppl):12s-16ss.
39. Zhu J, Peng T, Johnston C, et al. Immune surveillance by CD8alphaalpha skin-resident T cells in human herpes virus infection. Nature 2013;497:494-497.
40. Hayday A, Theodoridis E, Ramsburg E, et al. Intrae-pithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2001;2:997-1003. (Pubitemid 33069493)
41. Curry JL, Qin JZ, Robinson J, et al. Reactivity of resident immunocytes in normal and prepsoriatic skin using an ex vivo skin-explant model system. Arch Pathol Lab Med 2003;127:289-296. (Pubitemid 36378691)
42. Clark RA. Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 2010;130: 362-370.
43. Gebhardt T, Mackay LK. Local immunity by tissue-resident CD8() memory T cells. Front Immunol 2012;3:340.
44. Mueller SN, Gebhardt T, Carbone FR, et al. Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 2013;31:137-161.
45. Nestle FO, Di Meglio P, Qin JZ, et al. Skin immune sentinels in health and disease. Nat Rev Immunol 2009;9:679-691.
46. Yokomise H, Inui K, Wada H, et al. High-dose irradiation prevents rejection of canine tracheal allo-grafts. J Thorac Cardiovasc Surg 1994;107:1391-1397. (Pubitemid 24184974)